Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5202 | 1589 | 43.1 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SKP2 | Author keyword | 118 | 59% | 8% | 134 |
2 | P27KIP1 | Author keyword | 99 | 31% | 16% | 261 |
3 | P27 | Author keyword | 97 | 29% | 18% | 280 |
4 | CKS1 | Author keyword | 26 | 67% | 2% | 24 |
5 | S PHASE KINASE ASSOCIATED PROTEIN 2 | Author keyword | 21 | 75% | 1% | 15 |
6 | P57KIP2 | Author keyword | 18 | 35% | 3% | 43 |
7 | P27KIP1 GENE | Author keyword | 12 | 86% | 0% | 6 |
8 | P27KIP1 PROTEIN | Author keyword | 12 | 86% | 0% | 6 |
9 | JAB1 | Author keyword | 10 | 33% | 2% | 26 |
10 | CKS2 | Author keyword | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SKP2 | 118 | 59% | 8% | 134 | Search SKP2 | Search SKP2 |
2 | P27KIP1 | 99 | 31% | 16% | 261 | Search P27KIP1 | Search P27KIP1 |
3 | P27 | 97 | 29% | 18% | 280 | Search P27 | Search P27 |
4 | CKS1 | 26 | 67% | 2% | 24 | Search CKS1 | Search CKS1 |
5 | S PHASE KINASE ASSOCIATED PROTEIN 2 | 21 | 75% | 1% | 15 | Search S+PHASE+KINASE+ASSOCIATED+PROTEIN+2 | Search S+PHASE+KINASE+ASSOCIATED+PROTEIN+2 |
6 | P57KIP2 | 18 | 35% | 3% | 43 | Search P57KIP2 | Search P57KIP2 |
7 | P27KIP1 GENE | 12 | 86% | 0% | 6 | Search P27KIP1+GENE | Search P27KIP1+GENE |
8 | P27KIP1 PROTEIN | 12 | 86% | 0% | 6 | Search P27KIP1+PROTEIN | Search P27KIP1+PROTEIN |
9 | JAB1 | 10 | 33% | 2% | 26 | Search JAB1 | Search JAB1 |
10 | CKS2 | 9 | 83% | 0% | 5 | Search CKS2 | Search CKS2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P27 | 245 | 52% | 21% | 330 |
2 | P27KIP1 | 118 | 23% | 29% | 455 |
3 | DEPENDENT KINASE INHIBITOR | 107 | 21% | 29% | 460 |
4 | CDK INHIBITOR P27 | 71 | 60% | 5% | 77 |
5 | LIGASE SUBUNIT SKP2 | 59 | 81% | 2% | 35 |
6 | S PHASE KINASE | 56 | 74% | 3% | 42 |
7 | CDK INHIBITOR | 53 | 29% | 10% | 153 |
8 | KINASE INHIBITOR P27KIP1 | 43 | 35% | 6% | 99 |
9 | P27 EXPRESSION | 41 | 63% | 3% | 42 |
10 | SKP2 | 39 | 42% | 5% | 72 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy | 2008 | 387 | 198 | 67% |
CDK inhibitors: Cell cycle regulators and beyond | 2008 | 397 | 133 | 39% |
Regulation of the cdk inhibitor p27 and its deregulation in cancer | 2000 | 481 | 102 | 69% |
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer | 2008 | 357 | 183 | 31% |
Roles of F-box proteins in cancer | 2014 | 24 | 194 | 20% |
Targeting p27(Kip1) protein: its relevance in the therapy of human cancer | 2011 | 26 | 123 | 63% |
Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors | 2010 | 65 | 147 | 42% |
Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer | 2008 | 68 | 84 | 85% |
Post-translational regulation of the tumor suppressor p27(KIP1) | 2008 | 74 | 91 | 78% |
Another piece of the p27(Kip1) puzzle | 2007 | 37 | 17 | 94% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM MOL BIOL CELL BIOL GENET | 4 | 75% | 0.2% | 3 |
2 | TRANSLAT ADV ANIM HUMAN DIS | 4 | 23% | 1.0% | 16 |
3 | GEN SURG EMERGENCY ORGAN TRANSPLANTS | 2 | 67% | 0.1% | 2 |
4 | PHD PROGRAM ENVIRONM OCCUPAT MED | 2 | 67% | 0.1% | 2 |
5 | EMBRYON GENET ENGN | 2 | 18% | 0.6% | 10 |
6 | DEV GENETAOBA KU | 2 | 43% | 0.2% | 3 |
7 | MOL CELLULAR PATHOL THER Y | 2 | 19% | 0.4% | 7 |
8 | PERINATOGYNECOL | 1 | 31% | 0.3% | 4 |
9 | JIANGSU PROV NEUROREGENERAT | 1 | 12% | 0.7% | 11 |
10 | DEV BIOLAOBA KU | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000193589 | P21//P21WAF1 CIP1//WAF1 |
2 | 0.0000166232 | CYCLIN D1//CYCLIN E//CCND1 |
3 | 0.0000131889 | FBXW7//FBW7//HCDC4 |
4 | 0.0000129383 | COP9 SIGNALOSOME//NEDD8//NEDDYLATION |
5 | 0.0000077181 | P14ARF//P16//P16INK4A |
6 | 0.0000060487 | E2F//P107//P130 |
7 | 0.0000054010 | CAK//CDC2//CYCLIN A1 |
8 | 0.0000051337 | FLAVOPIRIDOL//CELL CYCLE REGULAT GRP//ROSCOVITINE |
9 | 0.0000049516 | ARID3B//JUMONJI//AT RICH INTERACTION DOMAIN |
10 | 0.0000041123 | UBCH10//ANAPHASE PROMOTING COMPLEX//GREATWALL |